This inventor holds 65 USPTO granted patents and 15 published patent applications, plus 9 CIPO patents and 36 EPO patents, primarily in Neurological Disorders (CPC class A61K). Top assignees: Pharnext, Genset, Serono Genetics Institute S.a.. Active years: 1999-2025.
Inventors with similar research interests:
Location History:
- Fontenay-sous-bois, FR (1999 - 2002)
- Neuilly-Sue-Seine, FR (2002)
- Paris, FR (2006)
- Neuilly-sur-Seine, FR (2001 - 2007)
- Le Vézinet, FR (2008)
- Saint Cloud, DE (2017)
- Le Vésinet, FR (2014 - 2020)
- Le Vesinet, FR (2013 - 2022)
- Saint Cloud, FR (2016 - 2023)
Company Filing History:
54 out of 54 
5 out of 20 
4 out of 62 Years Active: 1999-2025
Areas of Expertise:
Title: The Innovative Contributions of Daniel Cohen in Charcot-Marie-Tooth Disease Research
Introduction: Daniel Cohen, a prolific inventor based in Saint Cloud, France, holds an impressive portfolio of 65 patents primarily focused on medical treatments and therapies. His dedication to advancing the understanding and treatment of various medical conditions, particularly Charcot-Marie-Tooth Disease, has placed him at the forefront of medical innovation.
Latest Patents: Cohen's recent work reflects his commitment to combating Charcot-Marie-Tooth Disease type 1A (CMT1A). One of his noteworthy inventions provides methods for treating this condition through the administration of a combination of baclofen, sorbitol, and naltrexone, or their pharmaceutically acceptable salts. Additionally, he has developed compositions aimed at treating CMT and related disorders, further demonstrating his innovative approach to medical science.
Career Highlights: Throughout his career, Daniel Cohen has been associated with notable companies such as Pharnext and Genset, where he has contributed significantly to research and development in therapeutic solutions. His extensive experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to drive impactful innovations.
Collaborations: Cohen has collaborated with eminent professionals in the field, including Ilya Chumakov and Serguei Nabirochkin. These partnerships have fostered a dynamic research environment that encourages shared expertise and resources, ultimately enhancing the quality of innovations in medical treatment.
Conclusion: Daniel Cohen's impressive track record as an inventor highlights his significant contributions to the field of medical research, particularly in developing treatments for Charcot-Marie-Tooth Disease. His innovative patents and collaborative efforts continue to inspire advancements in healthcare, making a lasting impact on patients' lives.